A comprehensive toxicity study of zinc oxide nanoparticles versus their bulk in Wistar rats

Human and Experimental Toxicology - Tập 35 Số 12 - Trang 1286-1304 - 2016
Anurag Kumar Srivastav1, Mahadeo Kumar1, Nasreen Ghazi Ansari2, Abhishek Kumar Jain3, Jai Shankar4, Nidhi Arjaria4, Pankaj Jagdale5, Dhirendra Singh5
1Biochemistry Laboratory, GLP Test Facility, CSIR-Indian Institute of Toxicology Research, Lucknow, India
2Metal Analysis Laboratory, CSIR-Indian Institute of Toxicology Research, Lucknow, India
3Nanomaterial Toxicology Division, CSIR-Indian Institute of Toxicology Research, Lucknow, India
4Electron Microscopy Laboratory, CSIR-Indian Institute of Toxicology Research, Lucknow, India
5Central Pathology Laboratory, CSIR-Indian Institute of Toxicology Research, Lucknow, India

Tóm tắt

The purpose of this study was to characterize the zinc oxide nanoparticles (ZnO-NPs) and their bulk counterpart in suspensions and to access the impact of their acute oral toxicity at doses of 300 and 2000 mg/kg in healthy female Wistar rats. The hematological, biochemical, and urine parameters were accessed at 24 and 48 h and 14 days posttreatment. The histopathological evaluations of tissues were also performed. The distribution of zinc content in liver, kidney, spleen, plasma, and excretory materials (feces and urine) at 24 and 48 h and 14 days posttreatment were accessed after a single exposure at dose of 2000 mg/kg body weight. The elevated level of alanine amino transferase, alkaline phosphatase, lactate dehydrogenase, and creatinine were observed in ZnO-NPs at a dose of 2000 mg/kg at all time points. There was a decrease in iron levels in all the treated groups at 24 h posttreatment as compared to control groups but returned to their normal level at 14 days posttreatment. The hematological parameters red blood cells, hemoglobin, hematocrit, platelets, and haptoglobin were reduced at 48 h posttreatment at a dose of 2000 mg/kg ZnO-NPs and showed hemolytic condition. All the treated groups were comparable to control group at the end of 14 days posttreatment. The zinc concentration in the kidney, liver, plasma, feces, and urine showed a significant increase in both groups as compared to control. This study explained that ZnO-NPs produced more toxicological effect as compared to their bulk particles as evidenced through alteration in some hemato-biochemical parameters and with few histopathological lesions in liver and kidney tissues.

Từ khóa


Tài liệu tham khảo

Nounou H, 2013, Life Sci J, 10, 1969

10.1002/smll.200600134

10.1166/jnn.2005.182

10.1002/jbm.a.35241

10.1007/978-3-642-31470-4_2

Guerreiro-Tanomaru JM, 2013, Acta Odontol Latinoam, 26, 144

10.1517/17425247.2010.502560

10.1016/j.micres.2010.03.003

10.1111/j.1750-3841.2008.01013.x

Baek M, 2012, Int J Nanomedicine, 7, 3081

10.1007/s11051-007-9245-3

10.1002/jps.1143

10.1142/S0217979209061275

10.1016/j.toxlet.2005.08.007

Noel PC, 2012, Case Report Rapport de cas, 53, 383

10.1007/BF01689056

10.3390/ma5122850

10.1016/j.envpol.2007.01.016

OECD guideline (420) for testing of chemicals, Acute Oral Toxicity–Fixed Dose Procedure, Organization for Economic Corporation and Development

Renal function, https://en.wikipedia.org/wiki/Renal-function (accessed 21 August 2015).

10.1046/j.1365-2613.2003.00336.x

10.1039/C1CS15193B

10.1023/A:1016085108889

10.1080/10934520701792779

Zhang XZ. Study on the environmental behavior of titanium dioxide nanoparticles in aqueous environment. Doctoral dissertation Nankai University. Tianjin, P.R., China, 2006, (Chinese).

Adams LK, 2006, Water Res, 40

10.1021/es071235e

10.1021/es902121r

Mohanraj VJ, 2006, Trop J Pharmaceut Res, 5, 561

10.1021/tx900203v

10.3109/01480545.2012.720988

10.1039/c1em10197h

10.1166/jnn.2014.8876

10.1046/j.1460-9568.2000.00875.x

10.1021/es034979a

Johnston DE, 1999, Am Fam Physician, 59, 2223

Singh A, 2001, J Clinic Toxicol, 4, 001

Nanji AA, 1997, Alcohol Health & Research World, 21, 325

10.1097/00005768-200004000-00007

Wood K, 2011, Rev Urol, 13, 73

Rajak S, 2012, Int J Adv Sci Tech Res, 6, 81

10.1182/blood-2013-05-505016

Gupta S, 2011, Adv Hematol, 389854

10.1016/j.trstmh.2008.04.010

Kino K, 1980, J Bio Chem, 255, 9616, 10.1016/S0021-9258(18)43436-9

10.1309/V6GVYW2QTYD5C5PJ

10.1093/jn/136.5.1236

10.1080/02772248.2010.495191

10.1016/j.biomaterials.2010.07.045

Wang J, 2010, Int J Nanomed, 5, 861

10.1007/s00204-007-0253-y

10.1289/ehp.7339

10.3109/17435390.2010.509519

10.1007/s12272-011-0118-z

10.1186/1743-8977-8-18

Thông tin
Thông tin xuất bản

Human and Experimental Toxicology

Tập 35 Số 12

1286-1304

Thông tin tác giả